February 14th, 2018 Vancouver, British Columbia Tabu Equity Investments Inc. (the Company”) announces the addition of Mr. James Rutherford as Director and V.P of Project Development. James is CEO for NRP Organics and is responsible for running all facets of the business. James has a proven executive management track record and over 20 years of experience driving sales growth in the agriculture and technology industry. In addition to founding NRP Organics, James is the founder and CEO of “O Legado (1011849 BC Ltd.)” the focus of which is Humic and Fulvic based products for human consumption. Prior to founding O Legado and NRP Organics James served as a private consultant working with clients in the Health Canada MMAR, MMAP and LP programs, where he completed several multi-million dollar projects. James has attended Simon Fraser University(SFU) and The University of the Fraser Valley (UFV) where he studied business and sciences, and graduated from the University of British Columbia (UBC) Sauder School of Business.

Tabu Equity Investments Inc. invests in Canadian ACMPR applicants and licensed United States cannabis technology companies, as well as Canadian based support technologies for the cannabis industry. The company website can be found at: www.tabu.co

Statements in this news release that are forward-looking statements are subject to various risks and uncertainties concerning the specific factors disclosed here and elsewhere in Tabu’s periodic filings with Canadian securities regulators. When used in this news release, words such as “will, could, plan, estimate, expect, intend, may, potential, believe, should, aware” and similar expressions, are forward-looking  statements.  Forward-looking  statements  may  include,  without  limitation, statements including statements related to Tabu’s transactions and business related to cannabis and future news releases. Although Tabu has attempted to identify important factors that could cause actual  results,  performance  or  achievements  to  differ  materially  from  those  contained  in  the forward-looking  statements,  there  can  be  other  factors  that  cause  results,  performance  or achievements  not  to  be  as  anticipated,  estimated  or  intended,  including,  but  not  limited  to: dependence on obtaining regulatory approvals; investing in target companies or projects which have limited or no operating history and are engaged in activities currently considered illegal under US Federal laws; change in laws; limited operating history; reliance on management; requirements for  additional  financing;  competition;  hindering  market  growth  and  state  adoption  due  to inconsistent public opinion and perception of the medical-use and adult-use marijuana industry; and regulatory or political change.